Hepatitis C - Annual Epidemiological Report for 2017
In 2017, 31 273 cases of hepatitis C were reported in 29 EU/EEA Member States. Excluding countries that only reported acute cases, 31 178 cases corresponds to a crude rate of 7.3 cases per 100 000 population.
Annual epidemiological report 2011 [2009 data]
Reporting on 2009 surveillance data and 2010 epidemic intelligence data
- Antimicrobial resistance
- Avian influenza virus
- Food- and waterborne diseases
- Healthcare-associated infections
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Respiratory diseases
- Sexually transmitted infections
- Vaccine preventable diseases
- Viral hepatitis
Hepatitis B and C epidemiology in selected population groups in the EU/EEA
The findings presented in this report will be part of the process of developing a European guidance for HBV and HCV testing and may provide support EU/EEA countries in the development of national guidelines and in the design and scale-up of testing interventions.
Hepatitis E virus infection in Europe: Surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015
Aspinall, E.J., Couturier, E., Faber, M., Said, B., Ijaz, S., Tavoschi, L., Takkinen, J., Adlhoch, C.
PRECEPT: An evidence assessment framework for infectious disease epidemiology, prevention and control
Harder, T., Takla, A., Eckmanns, T., Ellis, S., Forland, F., James, R., Meerpohl, J.J., Morgan, A., Rehfuess, E., Schünemann, H., Zuiderent-Jerak, T., De Carvalho Gomes, H., Wichmann, O.
Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014
Miglietta, A., Quinten, C., Lopalco, P.L., Duffell, E.
HEVnet: A one health, collaborative, interdisciplinary network and sequence data repository for enhanced hepatitis e virus molecular typing, characterisation and epidemiological investigations
Mulder, A.C., Kroneman, A., Franz, E., Vennema, H., Tulen, A.D., Takkinen, J., Hofhuis, A., Adlhoch, C., Aberle, S., Subissi, L., Suin, V., Midgley, S., Kuznetsova, T., Izopet, J., Pavio, N., Baechlein, C., Baylisa, S.A., Corman, V.M., Fabera, M., Johne, R., Kamp, C., Wenzel, J.J., Coughlan, S., Di Bartolo, I., Bruni, R., Ciccaglionea, A.R., Garbuglia, A.R., Suffredini, E., Boxman, I., Hogema, B., van der Poel, W., Zaaijera, H., Sousaa, R., Velebit, B., Avellóna, A., Buti, M., Girones, R., Quer, J., Widén, F., Norder, H., Nyström, K., Bachofen, C., Sahli, R., Ijaza, S., Treagus, S., Kulka, M., Rizzi, V.
Options for national testing and surveillance for hepatitis E virus in the EU/EEA - Operational guidance
This operational guidance, developed by ECDC in collaboration with its hepatitis E virus (HEV) expert group, offers options on the implementation or adjustment of HEV surveillance at a national level.
Technical mission: HIV, STI and viral hepatitis in Bulgaria. 19-21 September 2016 and 14-15 November 2016
The Ministry of Health in Bulgaria invited ECDC to prepare an assessment of the current national HIV programme and to review the STI and Hepatitis surveillance system. Following discussions between ECDC and representatives of the Bulgarian national programme, it was decided to split the assessment into two separate country missions.
Hepatitis A virus in the EU/EEA, 1975–2014
A systematic review of seroprevalence and incidence comprising European surveillance data and national vaccination recommendations. This report provides a comprehensive picture of Hepatitis A virus (HAV) infection epidemiology in the EU/EEA between 1975 and 2014.